Page 10 - Read Online

Page 4 of 5 Zhang et al. Hepatoma Res 2023;9:5 https://dx.doi.org/10.20517/2394-5079.2023.11

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by the Shanghai municipal key clinical specialty (shslczdzk01302), the national
natural science foundation of China (81472278), and the Shanghai Shenkang hospital development center
clinical science and technology innovation project (SHDC12021109).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Lamarca A, Santos-Laso A, Utpatel K, et al; Group: on behalf of the European Network for the Study of Cholangiocarcinoma (ENS-
CCA). Liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system. Hepatology 2021;73:2311-25.
DOI PubMed PMC
2. Committee of Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version). [Expert consensus on
pathological diagnosis of intrahepatic cholangiocarcinoma (2022 version)]. Zhonghua Bing Li Xue Za Zhi 2022;51:819-27. DOI
PubMed
3. Lin J, Zhang H, Yu H, et al. Epidemiological characteristics of primary liver cancer in mainland china from 2003 to 2020: a
representative multicenter study. Front Oncol 2022;12:906778. DOI PubMed PMC
4. An L, Zheng R, Zhang S, et al. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in
China: estimates based on data from 188 population-based cancer registries. Hepatobiliary Surg Nutr 2023;12:45-55. DOI PubMed
PMC
5. Nakanuma Y, Klimstra D, Komuta M and Zen Y. Intrahepatic cholangiocarcinoma. In. WHO classification of tumours. Digestive
system tumours. 5th edition. Lyon: IARC Press; 2019. p. 254-259.
6. Zhou HB, Hu JY, Hu HP. Hepatitis B virus infection and intrahepatic cholangiocarcinoma. World J Gastroenterol 2014;20:5721-9.
DOI PubMed PMC
7. Lei Z, Xia Y, Si A, et al. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma
undergoing liver resection. J Hepatol 2018;68:655-62. DOI PubMed
8. Wang L, Zhu H, Zhao Y, et al. Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and
therapeutic experience. J Transl Med 2020;18:273. DOI PubMed PMC
9. Yamada M, Yamamoto Y, Sugiura T, et al. Comparison of the clinicopathological features in small bile duct and bile ductular type
intrahepatic cholangiocarcinoma. Anticancer Res 2019;39:2121-7. DOI PubMed
10. Hayashi A, Misumi K, Shibahara J, et al. Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic
cholangiocarcinoma. Am J Surg Pathol 2016;40:1021-30. DOI PubMed
11. Vijgen S, Terris B, Rubbia-Brandt L. Pathology of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2017;6:22-34. DOI
PubMed PMC
12. Nguyen Canh H, Takahashi K, Yamamura M, et al. Diversity in cell differentiation, histology, phenotype and vasculature of mass-
forming intrahepatic cholangiocarcinomas. Histopathology 2021;79:731-50. DOI PubMed
13. Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor
cell origin. Hepatology 2008;47:1544-56. DOI PubMed
14. Yamamoto M, Oshita A, Nishisaka T, Nakahara H, Itamoto T. Synchronous double primary hepatic cancer consisting of hepatocellular
carcinoma and cholangiolocellular carcinoma: a case report. J Med Case Rep 2018;12:224. DOI PubMed PMC
15. Chen J, He J, Qiu YD. Research advances on cholangiolocellular carcinoma. Chin J Hepatobiliary Surg 2016;22:784-7. DOI
16. Nakanuma Y, Sato Y, Ikeda H, et al. Intrahepatic cholangiocarcinoma with predominant “ductal plate malformation” pattern: a new
subtype. Am J Surg Pathol 2012;36:1629-35. DOI PubMed